scholarly journals P133 A Multidisciplinary Patient Education Programme Significantly Improves Asthma Control and Quality of Life in Patients with Severe Asthma: Abstract P133 Table 1

Thorax ◽  
2015 ◽  
Vol 70 (Suppl 3) ◽  
pp. A143.1-A143 ◽  
Author(s):  
RD Daly ◽  
LJ Holmes ◽  
H Scanlon ◽  
D Ryan ◽  
RM Niven
2017 ◽  
Vol 2017 ◽  
pp. 1-13 ◽  
Author(s):  
Christina Lutz ◽  
Stephanie Kersten ◽  
Christian T. Haas

Background.Although people with Multiple Sclerosis (pwMS) benefit from physical exercise, they still show reduced physical activity and exercise behaviour. This study aimed to investigate short- and long-term effects of an exercise-based patient education programme (ePEP) that focuses on empowering pwMS to a sustainable and self-regulated exercise training management.Methods.Fourteen pwMS were randomly assigned to immediate experimental group (EG-I:n=8) and waitlist-control group (EG-W:n=6) and attended biweekly in a six-week ePEP. All participants were measured for walking ability, quality of life, fatigue, and self-efficacy towards physical exercise before and after the ePEP, after 12 weeks, and one year after baseline. Short-term effects were analysed in a randomised control trial and long-term effects of all ePEP participants (EG-I + EG-W = EG-all) in a quasi-experimental design.Results.Only functional gait significantly improved in EG-I compared to EG-W (p=0.008,r=-0.67). Moderate to large effects were found in EG-all for walking ability. Not significant, however, relevant changes were detected for quality of life and fatigue. Self-efficacy showed no changes.Conclusion.The ePEP seems to be a feasible option to empower pwMS to a self-regulated and sustainable exercise training management shown in long-term walking improvements.


2010 ◽  
Vol 19 (Suppl 1) ◽  
pp. A40-A41
Author(s):  
M. F. Seronde ◽  
M. Nicolas ◽  
V. Descotes-Genon ◽  
R. Chopard ◽  
J. Dutheil ◽  
...  

2015 ◽  
Vol 8 ◽  
pp. A139
Author(s):  
Mary Jane Lisboa Valory ◽  
Norma Rubini ◽  
Albertina Varandas Capelo ◽  
Eliane Miranda Da Silva ◽  
Fernando Samuel Sion ◽  
...  

Author(s):  
Farnam Barati Sedeh ◽  
Anna Von Bülow ◽  
Vibeke Backer ◽  
Uffe Bødtger ◽  
Ulrik Søes Petersen ◽  
...  

2016 ◽  
Vol 48 (3) ◽  
pp. 726-733 ◽  
Author(s):  
Akke-Nynke van der Meer ◽  
Henk Pasma ◽  
Wilma Kempenaar-Okkema ◽  
Jo-Anneke Pelinck ◽  
Myrte Schutten ◽  
...  

Patients with uncontrolled asthma report ongoing symptoms, poor quality-of-life and extensive healthcare use (HCU) and might benefit from management by a specialised severe asthma team. It is unknown whether a one-time evaluation by asthma experts, without long-term supervision by a specialised team, provides favourable outcomes. We evaluated asthma control (Asthma Control Questionnaire; ACQ), quality-of-life (Asthma-related Quality of Life Questionnaire; AQLQ) and HCU before and 1 year after a 1-day visit programme in a severe asthma centre, including a multidisciplinary assessment resulting in a personalised management plan to be implemented by patients own pulmonologists.40 uncontrolled asthma patients completed questionnaires (ACQ, AQLQ, HCU) at baseline, and 6 and 12 months follow-up.ACQ improved from 2.6 (interquartile range 1.7–3.2) to 1.8 (1.2–3.2) (p=0.003) and AQLQ from 4.8 (4.0–5.2) to 5.3 (4.4–6.0) (p<0.001). We found a reduction in patients with ≥2 exacerbations (95% versus 17%; p<0.001), ≥1 emergency room visit (78% versus 37%; p<0.001) and ≥1 hospitalisation (47% versus 10%; p=0.001).Evaluation of uncontrolled asthma patients in a 1-day visit programme in a severe asthma centre resulted in significant improvements in asthma control, quality-of-life and healthcare use after 1 year. This 1-day visit approach seems beneficial for uncontrolled asthma patients and might reduce their dependence on expensive treatment modalities and long-term management in specialised centres.


2019 ◽  
Vol 55 (3) ◽  
pp. 1901509 ◽  
Author(s):  
Vanessa M. McDonald ◽  
Vanessa L. Clark ◽  
Laura Cordova-Rivera ◽  
Peter A.B. Wark ◽  
Katherine J. Baines ◽  
...  

RationaleTreatable traits have been proposed as a new paradigm for airway disease management.ObjectivesTo characterise treatable traits in a severe asthma population and to determine the efficacy of targeting treatments to these treatable traits in severe asthma.MethodsParticipants (n=140) with severe asthma were recruited to a cross-sectional study and underwent a multidimensional assessment to characterise treatable traits. Eligible participants with severe asthma (n=55) participated in a 16-week parallel-group randomised controlled trial to determine the feasibility and efficacy of management targeted to predefined treatable traits, compared to usual care in a severe asthma clinic. The patient-reported outcome of health-related quality of life was the trial's primary end-point.Main resultsParticipants with severe asthma had a mean±sd of 10.44±3.03 traits per person, comprising 3.01±1.54 pulmonary and 4.85±1.86 extrapulmonary traits and 2.58±1.31 behavioural/risk factors. Individualised treatment that targeted the traits was feasible and led to significantly improved health-related quality of life (0.86 units, p<0.001) and asthma control (0.73, p=0.01).ConclusionsMultidimensional assessment enables detection of treatable traits and identifies a significant trait burden in severe asthma. Targeting these treatable traits using a personalised-medicine approach in severe asthma leads to improvements in health-related quality of life, asthma control and reduced primary care acute visits. Treatable traits may be an effective way to address the complexity of severe asthma.


2011 ◽  
Vol 16 (4) ◽  
pp. 1129-1137 ◽  
Author(s):  
Faith S. Luyster ◽  
Mihaela Teodorescu ◽  
Eugene Bleecker ◽  
William Busse ◽  
William Calhoun ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document